Lyme Disease and Fibromyalgia Not Linked
the Clinical Pain Advisor take:
A previous link between Lyme disease and fibromyalgia has been disproved by a new, long-term study.
Compared with the general population, there is no increased prevalence of fibromyalgia in patients with Lyme disease, reported Gary P. Wormser, MD, of the New York Medical College in Valhalla, N.Y., and colleagues.
Previous studies had suggested that patients with Lyme disease may have an increased risk of fibromyalgia. However, these studies were conducted prior to the use of two-tier serologic testing for Lyme disease, and thus may have included patients who did not actually have Lyme disease. Additionally, these studies did not follow up with patients over an extended period of time.
The current study included 100 patients with Lyme disease, confirmed by the recovery of Borrelia burgdorferi from culture. Each patient was evaluated for fibromyalgia 11 to 20 years after the onset of Lyme disease.
Out of all the patients, 87 underwent a tender point examination. For a diagnosis of fibromyalgia, a patient must have at least 11 tender points or a total symptom score of ≥12. Only one patient met the criteria for a fibromyalgia diagnosis. The researchers noted that the prevalence in the study is consistent with fibromyalgia prevalence in the general population.
Compared with the general population, there is no increased prevalence of fibromyalgia in patients with Lyme disease.
Lyme disease is not a trigger for fibromyalgia, according to a long-term assessment of patients with culture-confirmed Lyme disease.
The prevalence of fibromyalgia among patients with culture-confirmed Lyme disease who were followed at the Lyme Disease Diagnostic Center in Westchester County, N.Y., for up to 20 years was no greater than that in the general population, say investigators at New York Medical College in Valhalla, N.Y., led by Gary P. Wormser, MD.
Earlier studies that suggested that Lyme disease may trigger fibromyalgia were performed before the use of two-tier serologic testing for Lyme disease and therefore may have included patients who did not actually have Lyme disease, the investigators wrote online in Arthritis & Rheumatology.
Clinical Pain Advisor Articles
- Replacing Sleep, Sedentary Behavior With Physical Activity Beneficial in Knee Osteoarthritis
- FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis
- Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis
- Rates of Concurrent Opioid, Sedative-Hypnotic Prescription Fills in Veterans
- Perioperative Pain Management in Patients With Opioid Use Disorder
- Ketamine: Mechanisms of Action, Uses in Pain Medicine, and Side Effects
- Medicinal Cannabis May Not Have Opioid-Sparing Effects in Chronic Noncancer Pain
- Cannabis May Be Effective for Migraine Treatment
- Chronic Neck Pain: Generators, Clinical Examination, MRI Findings, and Differential Diagnosis
- Should Drug Testing Be Implemented Before Prescribing Opioids and Benzodiazepines?
- Dexmedetomidine May Prolong Analgesia Duration in Nerve Blocks
- Reviewing the Efficacy of Intrathecal Morphine, Ziconotide for Cancer- and Noncancer Chronic Pain
- Cochrane Data Release and the Case for Open Science
- Pretreatment With Sumatriptan Can Reduce Cilostazol-Induced Headaches
- Effects of Pain, Depression, and Insomnia on Health Care Use in Older Adults With Osteoarthritis